K014034

Substantially Equivalent

MODIFICATION TO SYNCHRON LX CLINICAL CHEMISTRY SYSTEMS (LX20 AND LX20 PRO)

Applicant: Beckman Coulter, Inc.
Product code: JFL
Advisory panel: Clinical Chemistry
Date received: 2001-12-07
Decision date: 2001-12-18
Decision: Substantially Equivalent
Clearance type: Special
Location: Brea, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.